Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

VISN 6 > Research > Interventions

full logo

jump to:  Research Home | Neurocognition | Neuroimaging | 
Genetics | Neuroscience | Health Services 

Clinical Interventions & Metabolomics Lab
The overarching goal of this research lab is to identify and implement new pharmacological and behavioral treatment strategies that are maximally effective for disorders impacting OEF/OIF/OND Veterans. This lab is also investigating candidate neurosteroid, other small molecule, and protein biomarkers that are potentially relevant to the pathophysiology and treatment of post-deployment mental health. Neurosteroid investigations utilize a highly sensitive and specific state-of-the-art technique that is mass spectrometry-based. This method can reliably quantify neurosteroids with a sensitivity of two trillionths of a gram (2 x 10-12 grams or 2 picograms). A number of pharmacological agents that are effective for PTSD and depression increase neurosteroids (including selective serotonin reuptake inhibitors or SSRIs), and these molecules may thus contribute to their therapeutic efficacy. Furthermore, certain neurosteroids enhance learning and memory in rodent models. It is therefore logical to target these compounds directly as agents for pharmacological intervention. Current randomized placebo-controlled double-blind clinical trials include a project targeting the secondary prevention of PTSD with paroxetine in OEF/OIF/OND Veterans. Additional studies that are now actively enrolling utilize a novel neurosteroid intervention to treat cognitive symptoms in Veterans with PTSD and schizophrenia. The Clinical Interventions & Metabolomics Lab also investigates the neurobiological underpinnings of suicidal behaviors and the role of neurosteroids in nicotine dependence. Improved clinical interventions are urgently needed to address the post-deployment mental health needs of OEF/OIF/OND Veterans. The primary mission of this research lab is to investigate new treatments that integrate both bench and bedside endeavors by translating basic science findings to new clinical interventions that will positively impact Veteran health.

Director - Christine Marx, M.D.
marx0001@mc.duke.edu  |  christine.marx@va.gov

Assistant Director - Jennifer Naylor, Ph.D..
naylorjc@duke.edu  |  jennifer.naylor2@va.gov

Contact

Durham VAMC Site
Study Coordinator
919-416-5915
mirecc.studies@va.gov

Richmond VAMC Site
Robin Lumpkin
804-675-5000 Ext. 4251
robin.lumpkin@va.gov

Salisbury VAMC Site
Mary Peoples
704-638-9000 Ext. 12956
mary.peoples1@va.gov